Literature DB >> 10737561

Aortic atherosclerosis is a marker for significant coronary artery disease.

E Acartürk1, M Demir, M Kanadaşi.   

Abstract

Atherosclerosis is a generalized process that may involve the entire vasculature as well as the coronary arteries. Aortic atherosclerosis (AA) is associated with an increased risk for recurrent ischemic stroke and cardiovascular death and can be diagnosed by transesophageal echocardiography (TEE). We performed TEE in 60 patients (47 men and 13 women; age range 37-78, mean 53.5 +/- 9.9) who underwent coronary angiography, to assess whether atherosclerosis in the thoracic aorta correlates with coronary artery disease (CAD) or may be a marker for it. Significant CAD was defined as either > 50% reduction of internal diameter of the left main coronary artery or > 70% reduction of the internal diameter in the anterior descending, right coronary or circumflex artery. The number of diseased vessels was based on the Coronary Artery Surgery Study criteria. A grading system was used to detect AA. The thoracic aorta was considered to be normal and classified as grade I when the internal surface was smooth and without lumen irregularities or increased echo-intensity. Grade II changes consisted of increased echodensity of the intima without lumen irregularity or thickening. Grade III changes consisted of increased echodensity of intima with well defined atheroma extending < 3 mm in the aorta. Grade IV and V changes consisted of atheroma > 3 mm and protruding mobile plaques, respectively. Grades III-V were considered as AA. Twenty two of the 29 patients (75.9%) with CAD and 10 of the 31 patients (32.3%) without CAD had AA detected by TEE. There was a significant relationship between CAD and AA (r = 0.44, p < 0.001). The sensitivity and specificity of AA in detecting CAD were 75.9% and 67.7%, respectively. Our data suggest that AA is common in patients with significant CAD. Detection of AA by TEE may be a marker for CAD and early detection of aortic atherosclerosis may contribute to diagnostic and therapeutic interventions and thereby improve the prognosis.

Entities:  

Mesh:

Year:  1999        PMID: 10737561     DOI: 10.1536/jhj.40.775

Source DB:  PubMed          Journal:  Jpn Heart J        ISSN: 0021-4868


  6 in total

1.  Indices of aortic distensibility and coronary flow velocity reserve in patients with different grades of aortic atherosclerosis.

Authors:  Attila Nemes; Tamás Forster; Miklós Csanády; Noémi Gruber
Journal:  Int J Cardiovasc Imaging       Date:  2004-08       Impact factor: 2.357

2.  Significance of the intima-media thickness of the thoracic aorta in patients with coronary atherosclerosis.

Authors:  Jang-Ho Bae; Eberhard Bassenge; Ki-Rack Park; Ki-Young Kim; Michael Schwemmer
Journal:  Clin Cardiol       Date:  2003-12       Impact factor: 2.882

3.  Normal thoracic aorta diameter on cardiac computed tomography in healthy asymptomatic adults: impact of age and gender.

Authors:  Song Shou Mao; Nasir Ahmadi; Birju Shah; Daniel Beckmann; Annie Chen; Luan Ngo; Ferdinand R Flores; Yan Lin Gao; Matthew J Budoff
Journal:  Acad Radiol       Date:  2008-07       Impact factor: 3.173

4.  The comparative value of the aortic atherosclerosis and the coronary flow velocity reserve evaluated by stress transesophageal echocardiography in the prediction of patients with aortic stenosis with coronary artery disease.

Authors:  Attila Nemes; Tamás Forster; Attila Thury; Zsolt Kovács; Krisztina Boda; Miklós Csanády
Journal:  Int J Cardiovasc Imaging       Date:  2003-10       Impact factor: 2.357

5.  Thoracic aortic atheroma severity predicts high-risk coronary anatomy in patients undergoing transesophageal echocardiography.

Authors:  Xuedong Shen; Wilbert S Aronow; Chandra K Nair; Hema Korlakunta; Mark J Holmberg; Fenwei Wang; Stephanie Maciejewski; Dennis J Esterbrooks
Journal:  Arch Med Sci       Date:  2011-03-08       Impact factor: 3.318

6.  Plasma Ceramides as Prognostic Biomarkers and Their Arterial and Myocardial Tissue Correlates in Acute Myocardial Infarction.

Authors:  Leonardo P de Carvalho; Sock Hwee Tan; Ghim-Siong Ow; Zhiqun Tang; Jianhong Ching; Jean-Paul Kovalik; Sock Cheng Poh; Chee-Tang Chin; A Mark Richards; Eliana C Martinez; Richard W Troughton; Alan Yean-Yip Fong; Bryan P Yan; Aruni Seneviratna; Vitaly Sorokin; Scott A Summers; Vladimir A Kuznetsov; Mark Y Chan
Journal:  JACC Basic Transl Sci       Date:  2018-05-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.